title: A systematic review of the effectiveness, cost-effectiveness and barriers to implementation of thrombolytic and neuroprotective therapy for acute ischaemic stroke in the NHS.
authors.affiliation: Department of Clinical Neurosciences, University of Edinburgh, Western General Hospital, Edinburgh, Scotland.
authors.forename: P
authors.initials: P
authors.lastname: Sandercock
authors.forename: E
authors.initials: E
authors.lastname: Berge
authors.forename: M
authors.initials: M
authors.lastname: Dennis
authors.forename: J
authors.initials: J
authors.lastname: Forbes
authors.forename: P
authors.initials: P
authors.lastname: Hand
authors.forename: J
authors.initials: J
authors.lastname: Kwan
authors.forename: S
authors.initials: S
authors.lastname: Lewis
authors.forename: R
authors.initials: R
authors.lastname: Lindley
authors.forename: A
authors.initials: A
authors.lastname: Neilson
authors.forename: B
authors.initials: B
authors.lastname: Thomas
authors.forename: J
authors.initials: J
authors.lastname: Wardlaw
mesh_terms: D002545:Brain Ischemia / Q000188:drug therapy / Q000191:economics; D003362:Cost-Benefit Analysis; D004059:Diffusion of Innovation; D006801:Humans; D018696:Neuroprotective Agents / Q000191:economics / Q000627:therapeutic use*; D013222:State Medicine / Q000458:organization & administration*; D020521:Stroke / Q000188:drug therapy* / Q000191:economics; D015912:Thrombolytic Therapy / Q000191:economics*; D016896:Treatment Outcome; D006113:United Kingdom
chemical_list: D018696:Neuroprotective Agents